ReviewWorld journal of gastroenterology2015
Surgical recurrence in Crohn's disease: Are we getting better?
Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02952131 (Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
Who cites it
11 citing papers in PubMed, 18 citations in OpenAlex.
- Minimally invasive surgery in Crohn's disease: state-of-the-art review.Frontiers in surgery · 2023Review
- Short-term and long-term outcomes of laparoscopicWorld journal of gastroenterology · 2021Article
- Does microscopic involvement of the surgical margins after ileocecectomy in Crohn's patients predict early recurrence?International journal of colorectal disease · 2021Article
- Review
- Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's Disease.Gut and liver · 2020Article
- Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn's disease.Wiener klinische Wochenschrift · 2018Article
- The modified Glasgow prognostic score in Crohn's disease-does it predict short-term outcome?European surgery : ACA : Acta chirurgica Austriaca · 2018Article
- Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease.World journal of gastroenterology · 2017Article
- Systems Pharmacological Approach ofEvidence-based complementary and alternative medicine : eCAM · 2017Article
- Minimal-invasive approach for penetrating Crohn's disease is not associated with increased complications.Surgical endoscopy · 2016Article
- Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review.Medicine · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's disease (CD) still remains a challenging chronic inflammatory disorder, both for colorectal surgeons and gastroenterologists. The need for recurrent surgery following primary intestinal resection is still considerable, though recent evidence suggested a declining rate of recurrence. Several conflicting surgical parameters have been identified that might impact on the postoperative outcome positively, such as access to the abdomen, anastomotic configuration or type of disease. Additionally, promising results have been achieved with the increased use of immunosuppressive medications in CD. Consequently, the question arises if we are getting better as a result of novel medical and surgical strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.